Exposure to gold nanoparticles produces cardiac tissue damage that depends on the size and duration of exposure

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Abdelhalim, Mohamed Anwar K ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

cytoplasmic vacuolization; gold nanoparticles; heart muscle; histology; inflammatory; nanotoxicity; rats; size

Indexed keywords

GOLD NANOPARTICLE; GOLD; METAL NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; EXTRAVASATION; HEART MUSCLE; HEART MUSCLE INJURY; HISTOLOGY; INFLAMMATORY CELL; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; PARTICLE SIZE; PLASMA CELL; PROTEIN INTERACTION; RAT; VASCULAR DISEASE; ANIMAL; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CORONARY BLOOD VESSEL; DRUG EFFECT; HEART INJURY; PATHOLOGY; RANDOMIZATION; WISTAR KYOTO RAT;

ANIMALIA; RATTUS;

ANIMALS; CORONARY VESSELS; GOLD; HEART INJURIES; MALE; METAL NANOPARTICLES; MYOCARDIUM; PARTICLE SIZE; RANDOM ALLOCATION; RATS; RATS, INBRED WKY;

EID: 81055150444     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-205     Document Type: Article

References (42)

1. Cellular fate of modular DNA delivery system mediated by silica nanoparticles. Gemeinhart RA, Luo D, Saltzman WM, Biotechn Prog 2005 21 532 537 (Pubitemid 40466426)
2. Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery. Yoo HS, Lee JE, Chung H, Kwon IC, Jeong SY, J Control Release 2005 103 235 243 10.1016/j.jconrel.2004.11.033 15710514 (Pubitemid 40248575)
3. Optimal tracking of organically modfied silica nanoparticles as DNA carriers: a nonviral, nanomedicine approach for gene delivery. Roy I, Ohulchanskyy TY, Bharali DJ, Pudavar HE, Mistretta RA, Kaur N, Prasad PN, Proc Natl Acad Sci USA 2005 102 297 284 10.1073/pnas.0406352102 15625113 (Pubitemid 40116761)
4. Nanotechnology blooms, at last. Gordon EM, Hall FL, Oncol Rep 2005 13 1003 1007 15870914
5. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Oberdörster G, Oberdörster E, Oberdörster J, Environ Health Perspect 2005 113 823 839 10.1289/ehp.7339 16002369 (Pubitemid 40984181)
6. Toxicological hazards of inhaled nanoparticles-potential implications for drug delivery. Borm PJ, Kreyling WG, J Nanoscience Nanotechnol 2004 4 521 531 10.1166/jnn.2004.081 (Pubitemid 39387404)
7. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD, Small 2005 1 325 327 10.1002/smll.200400093 17193451 (Pubitemid 43951781)
8. MspA porin-gold nanoparticle assemblies: enhanced binding through a controlled cysteine mutation. Dani RK, Kang M, Kalita M, Smith PE, Bossmann SH, Chikan V, Nano Lett 2008 8 1229 1236 10.1021/nl072658h 18318505
9. Surface-functionalized nanoparticle library yields probes for apoptotic cells. Schellenberger EA, Reynolds F, Weissleder R, Josephson L, Chembiochem 2004 5 275 279 10.1002/cbic.200300713 14997519 (Pubitemid 39257120)
10. Mechanism of lung injury caused by PM10 and ultrafine particles with special reference to COPD. MacNee W, Donaldson K, Eur Respir J 2003 40 47S 51S (Pubitemid 36565582)
11. Potential oxidative stress of gold Nanoparticles by induced-NO releasing in serum. Jia HY, Liu Y, Zhang XJ, Han L, Du LB, Tian Q, Yc X, J am Chem Soc 2009 131 1 40 1 10.1021/ja808033w 19072650
12. Toxic characteristics of methoxy poly(ethylene glycol)/poly(- caprolactone) nanospheres; in vitro and in vivo studies in the normal mice. Kim SY, Lee YM, Baik DJ, Kang JS, Biomaterials 2003 24 55 63 10.1016/S0142-9612(02) 00248-X 12417178 (Pubitemid 35300203)
13. Modification of gold nanorods using phosphatidylcholineto reduce cytotoxicity. Takahashi H, Niidome Y, Niidome T, Kaneko K, Kawasaki H, Yamada S, Langmuir 2006 22 1 2 5 10.1021/la0520029 16378388 (Pubitemid 43063513)
14. Size-dependent cytotoxicity of gold nanoparticles. Pan Y, Neuss S, Leifert A, Fischler M, Wen F, Simon U, Schmid G, Brandau W, Jahnen-Dechent W, Small 2007 3 11 1941 1949 10.1002/smll.200700378 17963284 (Pubitemid 350099867)
15. Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice. BarathManiKanth S, Kalishwaralal K, Sriram M, Pandian SRK, Youn H, Eom S, Gurunathan G, Journal of Nanobiotechnology 2010 8 16 10.1186/1477-3155-8-16 20630072
16. In vitro toxicity of nanoparticles in BRL-3A rat liver cells. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ, Toxicol in Vitro 2005 19 975 983 10.1016/j.tiv.2005.06.034 16125895 (Pubitemid 41563236)
17. Can silver nanoparticles be useful as potential biological labels? Schrand AM, Bradich-Stolle LK, Schlager JJ, Dai L, Hussain SM, Nanotechnology 2008 9 1 13
18. Biomedical applications and potential health risks of nanomaterials: molecular mechanisms. Lanone S, Boczkowski J, Curr Mol Med 2006 6 651 63 10.2174/156652406778195026 17022735 (Pubitemid 44377764)
19. Histochemistry. Theoritical and applied. Analytical technology. Pearse AE, Churchill-Livingstone, Edinburgh 4 1985 2
20. Gold nanoparticles administration induced prominent inflammatory, central vein intima disruption, fatty change and Kupffer cells hyperplasia. Abdelhalim MAK, Jarrar BM, Lipids in Health and Disease 2011 10 133 10.1186/1476-511X-10- 133 21819574
21. The appearance of renal cells cytoplasmic degeneration and nuclear destruction might be an indication of GNPs toxicity. Abdelhalim MAK, Jarrar BM, Lipids in Health and Disease 2011 10 147 10.1186/1476-511X-10-147 21859444
22. Renal tissue alterations were size-dependent with smaller ones induced more effects and related with time exposure of gold nanoparticles. Abdelhalim MAK, Jarrar BM, Lipids in Health and Disease 2011 10 163 10.1186/1476-511X-10- 163 21936889
23. Gold nanoparticles induced cloudy swelling to hydropic degeneration, cytoplasmic hyaline vacuolation, polymorphism, binucleation, karyopyknosis, karyolysis, karyorrhexis and necrosis in the liver. Abdelhalim MAK, BM, Lipids in Health and Disease 2011 10 166 10.1186/1476-511X-10-166 21939512
24. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Reddy JK, Rao MS, Am J Physiol Gastrointest Liver Physiol 2006 290 5 852 8 16603729
25. Oxidative stress and toxicity of gold nanoparticles in Mytilus edulis. Tedescoa S, Doyleb H, Blascoc J, Redmondb G, Sheehana D, Aquatic Toxicology 2010 100 178 186 10.1016/j.aquatox.2010.03.001 20382436
26. 5'-Adenosinephosphosulphate reductase (CysH) protects Mycobacterium tuberculosis against free radicals during chronic infection phase in mice. Senaratne RH, De Silva AD, Williams SJ, Mougous JD, Reader JR, Zhang TJ, Chan S, Sidders B, Lee DH, Chan J, Bertozzi CR, Riley LW, Mol Microbiol 2006 59 1744 1753 10.1111/j.1365-2958.2006.05075.x 16553880
27. Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Pan Y, Leifert A, Ruau D, Neuss S, Bornemann J, Schmid G, Wolfgang B, Ulrich S, Willi J-D, Small 2009 5 2067 2076 10.1002/smll.200900466 19642089
28. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Lasagna-Reeves C, Gonzalez-Romero D, Barria MA, Olmedo I, Clos A, Sadagopa Ramanujam VM, Urayama A, Vergara L, Kogan MJ, Soto C, Biochemical and Biophysical Research Communications 2010 393 649 655 10.1016/j.bbrc.2010.02.046 20153731
29. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Lasagna-Reeves C, Gonzalez-Romero D, Barria MA, Olmedo I, Clos A, Sadagopa Ramanujam VM, Urayama A, Vergara L, Kogan MJ, Soto C, Biochemical and Biophysical Research Communications 2010 393 649 655 10.1016/j.bbrc.2010.02.046 20153731
30. Toxic potential of materials at the nanolevel. Nel A, Xia T, Mädler L, Li N, Science 2006 311 622 627 10.1126/science.1114397 16456071 (Pubitemid 43191298)
31. Metals mimic airway epithelial injury induced by in vitro exposure to Utah Valley ambient particulate matter extracts. Pagan I, Costa DL, McGee JK, Richards JH, Dye JA, J Toxicol Environ Health 2003 66A 1087 1112 (Pubitemid 36859666)
32. The role of particulate pollutants in pulmonary inflammation and asthma: Evidence for the involvement of organic chemicals and oxidative stress. Nel AE, Diaz-Sanchez D, Li N, Curr Opin Pulmon Med 2001 7 20 26 10.1097/00063198- 200101000-00004 (Pubitemid 32003169)
33. Current hypotheses on the mechanism of toxicity of ultrafine particles. Donaldson K, Stone V, Ann Ist Super Sanit 2003 39 405 410 (Pubitemid 38418409)
34. Ultrafine particles. Donaldson K, Stone V, Clouter A, Renwick L, MacNee W, Occup Environ Med 2001 58 211 216 10.1136/oem.58.3.211 11171936
35. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Oberdörster G, Oberdörster E, Oberdörster J, Environ Health Perspect 2005 113 823 839 10.1289/ehp.7339 16002369 (Pubitemid 40984181)
36. Exposure to carbon nanotuibe material: assessment of nanotube cytoyoxicity using human keratinocyte cells. Shvedova AA, Castranova V, Kisin ER, Schwegler-Berry D, Murray AR, Gandelsman VZ, Maynard A, Baron P, J Toxicol Environ Health 2003 66A 1909 1926 (Pubitemid 37352634)
37. Size dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K, Toxicol Appl Pharmacol 2001 175 191 199 10.1006/taap.2001.9240 11559017 (Pubitemid 32917742)
38. Modulation of Kupffer cell activity: physio-pathological consequences on hepatic metabolism. Neyrinck A, Bull Mem Acad R Med Belg 2004 159 5-6 358 66 15693545
39. Swelling of hepatocytes injured by oxidative stress suggests pathological changes related to macromolecular crowding. Del Monte U, Medical Hypotheses 2005 64 4 818 825 10.1016/j.mehy.2004.08.028 15694703 (Pubitemid 40203072)
40. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. Oberdörster G, Sharp Z, Atudorei V, Elder ACP, Gelein R, Lunts A, Kreyling W, Cox C, J Toxicol Environ Health 2002 65A 1531 1543 (Pubitemid 35217499)
41. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. Kreyling WG, Semmler M, Erbe F, Mayer P, Takenaka S, Schulz H, Oberdörster G, Ziesenis A, J Toxicol Environ Health 2002 65 Part A 1513 1530 (Pubitemid 35217498)
42. Nanotoxicology. Donaldson K, Stone V, Tran CL, Kreyling W, Borm PJA, Occup Environ Med 2004 61 727 728 10.1136/oem.2004.013243 15317911 (Pubitemid 39178799)